Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole PPK/PD and individualized treatment in patients with liver dysfunction
ChiCTR1800019472Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of voriconazole in invasive mycoses (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Plasma drug concentration, Clinical efficacy/outcomes and 2 more. Started Nov 2018; status: recruiting.
02
Drugs
voriconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR1800019472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019472.